Workflow
上市公司重大资产重组
icon
Search documents
阳谷华泰: 第六届董事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-08-13 16:23
Group 1 - The company held its 12th meeting of the 6th Board of Directors on August 13, 2025, with all 7 directors present, including 3 independent directors [1] - The board approved several proposals, including adjustments to the asset acquisition plan and related party transactions [2][5] - The company plans to acquire 99.64% of the equity of Bomi Technology Co., Ltd. for a transaction price of 143.79 million yuan, down from 100% and 144.30 million yuan respectively [2][3] Group 2 - The board's decision to adjust the transaction does not constitute a major adjustment under relevant regulations, as the changes in transaction parties and asset percentages are within acceptable limits [2][4] - The company will also terminate the agreement with Meng Xianwei regarding the asset acquisition [5] - The board approved the use of idle funds for cash management, allowing up to 30 million yuan of temporarily idle raised funds and 60 million yuan of self-owned funds for safe and liquid investments [6][7]
阳谷华泰: 关于本次交易方案调整不构成重大调整的公告
Zheng Quan Zhi Xing· 2025-08-13 16:23
Core Viewpoint - The company, Shandong Yanggu Huatai Chemical Co., Ltd., is adjusting its asset acquisition and fundraising plan, which involves changes in the transaction structure and the percentage of equity being acquired in the target company, Bomi Technology Co., Ltd. [1][2] Group 1: Transaction Adjustments - The company has revised its acquisition of Bomi Technology Co., Ltd. from 100% to 99.64% of the equity [1] - The transaction price has been adjusted from 144,304.25 million yuan to 143,790.84 million yuan [1] - The adjustments do not constitute a major change to the restructuring plan as per relevant regulations [2][3] Group 2: Decision-Making Process - The adjustments were approved during the 11th meeting of the 6th Board of Directors and the 8th meeting of the 6th Supervisory Board held on June 27, 2025, and further adjustments were approved in the 12th meeting on August 13, 2025 [1][3] - Prior to the board's review, an independent director meeting was held to assess the related proposals, which received approval [3] Group 3: Independent Financial Advisor's Opinion - The independent financial advisor, Zhongtai Securities Co., Ltd., confirmed that the adjustments do not constitute a major change to the restructuring plan according to the relevant regulations [3]
阳谷华泰: 山东阳谷华泰化工股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易报告书(草案)摘要(修订稿)
Zheng Quan Zhi Xing· 2025-08-13 16:23
Core Viewpoint - Shandong Yanggu Huatai Chemical Co., Ltd. plans to issue shares and pay cash to acquire 99.64% of the equity of Bomi Technology Co., Ltd. and raise supporting funds through a related party transaction [1][6]. Summary by Sections Transaction Details - The transaction involves the purchase of assets from multiple parties, including Hainan Juxin, Wang Chuanhua, Wu Fengyun, and others [1]. - The company intends to raise funds from no more than 35 specific investors as per the regulations of the China Securities Regulatory Commission [1]. Financial and Legal Commitments - The company and its board members guarantee the accuracy and completeness of the restructuring report and its summary, assuming legal responsibility for any false statements or omissions [2][3]. - The controlling shareholders and actual controllers commit to not transferring their shares during the investigation period if any information provided is found to be misleading or false [2][5]. Regulatory Compliance - The restructuring report does not represent any substantive judgment or approval from the China Securities Regulatory Commission or the Shenzhen Stock Exchange [3]. - The effectiveness and implementation of the transaction are subject to the approval of regulatory authorities [3]. Adjustments to the Restructuring Plan - The company held board meetings to approve adjustments to the restructuring plan, including changes to the parties involved in the transaction [11][12]. - The performance commitment period for the transaction is set for four consecutive accounting years starting from the year of completion, with specific profit targets outlined for the years 2025 and 2026 [13][14].
阳谷华泰: 中泰证券股份有限公司关于本次交易方案调整不构成重大调整的核查意见
Zheng Quan Zhi Xing· 2025-08-13 16:23
Core Viewpoint - The adjustment of the transaction plan by Shandong Yanggu Huatai Chemical Co., Ltd. does not constitute a significant change according to relevant regulations and guidelines [1][2][3] Group 1: Transaction Adjustment Details - The company held multiple board meetings to review and approve the adjusted transaction plan, with the latest meeting on August 13, 2025 [1] - The specific adjustments include a reduction in the stake of the target asset from 100% to 99.64% and a slight decrease in the transaction price from 1,443.0425 million yuan to 1,437.9084 million yuan [1] Group 2: Regulatory Compliance - The adjustments made to the transaction plan are deemed not to constitute a significant change as they meet the criteria outlined in the "Major Asset Restructuring Management Measures" [2] - The reduction of one trading party and the corresponding asset share does not exceed 20% of the original transaction price, total assets, net assets, and operating income, thus qualifying for the exemption from being classified as a significant adjustment [2] Group 3: Independent Financial Advisor's Opinion - The independent financial advisor has confirmed that the adjustments to the transaction plan do not constitute a significant change based on the relevant regulations [3]
海兰信: 董事会关于本次交易符合《上市公司重大资产重组管理办法》第十一条、第四十三条和第四十四条规定的说明
Zheng Quan Zhi Xing· 2025-08-12 16:26
Group 1 - The company plans to acquire 100% equity of Hainan Hailan Universe Marine Information Technology Co., Ltd. from 17 shareholders through a combination of issuing shares and cash payment [1] - The transaction is in compliance with the relevant provisions of the "Measures for the Administration of Major Asset Restructuring of Listed Companies," specifically Articles 11, 43, and 44 [1] - The asset pricing method is fair and does not harm the legitimate rights and interests of the company and its shareholders [1] Group 2 - The company confirms that there are no ongoing investigations or allegations of illegal activities by the China Securities Regulatory Commission that would affect the transaction [1] - The financial condition of the company has not undergone significant adverse changes that would lead to major negative impacts from the transaction [1] - The transaction can be completed within the agreed timeframe under the conditions and procedures set forth [1]
海兰信: 国泰海通证券股份有限公司作为北京海兰信数据科技股份有限公司独立财务顾问在充分尽职调查和内部核查的基础上出具的承诺函
Zheng Quan Zhi Xing· 2025-08-12 16:26
Group 1 - The independent financial advisor, Guotai Junan Securities Co., Ltd., has been appointed by Beijing Hailanxin Data Technology Co., Ltd. to conduct due diligence and internal verification for the transaction involving the issuance of shares and cash payment for asset acquisition [1] - The independent financial advisor has committed that their professional opinions do not differ materially from the content disclosed by the listed company [1] - The disclosed documents meet the required content and format standards, and the restructuring plan complies with relevant laws, regulations, and the requirements of the China Securities Regulatory Commission and Shenzhen Stock Exchange [1] Group 2 - The independent financial advisor has ensured that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions [1] - Strict confidentiality measures and risk control protocols are in place to prevent insider trading, market manipulation, and securities fraud [1]
海兰信: 国泰海通证券股份有限公司关于北京海兰信数据科技股份有限公司本次重组前12个月内购买、出售资产的核查意见
Zheng Quan Zhi Xing· 2025-08-12 16:26
经核查,独立财务顾问认为,截至本核查意见出具之日,在本次交易前十二 个月内,上市公司不存在《上市公司重大资产重组管理办法》规定的与本次交易 相关的购买、出售资产的交易行为,不存在需纳入本次交易的累计计算范围的情 况。 (以下无正文) 国泰海通证券股份有限公司 关于北京海兰信数据科技股份有限公司本次重组前 12 个月内 购买、出售资产的核查意见 北京海兰信数据科技股份有限公司(以下简称"公司"或"上市公司")拟 通过发行股份及支付现金方式购买海南省信息产业投资集团有限公司等海南海 兰寰宇海洋信息科技有限公司(以下简称"海兰寰宇"或"标的公司")全体 17 名股东(以下简称"交易对方")合计持有的海兰寰宇 100%股权(以下简称"标 的资产"),同时拟向不超过 35 名特定投资者发行股票募集配套资金(以下简称 "本次交易"或"本次重组")。 根据《上市公司重大资产重组管理办法》第十四条的规定:"上市公司在十 二个月内连续对同一或者相关资产进行购买、出售的,以其累计数分别计算相应 数额。已按照本办法的规定编制并披露重大资产重组报告书的资产交易行为,无 须纳入累计计算的范围。中国证监会对本办法第十三条第一款规定的重大 ...
海兰信: 国泰海通证券股份有限公司关于本次重组相关主体不存在依据《上市公司监管指引第7号——上市公司重大资产重组相关股票异常交易监管》第十二条不得参与任何上市公司重大资产重组情形的核查意见
Zheng Quan Zhi Xing· 2025-08-12 16:25
北京海兰信数据科技股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易项目 国泰海通证券股份有限公司关于 二条不得参与任何上市公司重大资产重组情形的核查意见 北京海兰信数据科技股份有限公司(以下简称"公司"或"上市公司")拟 通过发行股份及支付现金方式购买海南省信息产业投资集团有限公司等海南海 兰寰宇海洋信息科技有限公司(以下简称"海兰寰宇")全体 17 名股东(以下 简称"交易对方")合计持有的海兰寰宇 100%股权,同时拟向不超过 35 名特 定投资者发行股票募集配套资金(以下简称"本次交易")。 张 铎 王立泉 国泰海通证券股份有限公司(以下简称 "独立财务顾问")作为本次交易 的独立财务顾问,就本次重组相关主体是否存在《上市公司监管指引第 7 号— —上市公司重大资产重组相关股票异常交易监管》第十二条规定不得参与任何 上市公司重大资产重组的情形进行了核查,核查意见如下: 本次交易涉及的相关主体不存在因涉嫌与任何上市公司重大资产重组相关 的内幕交易被立案调查或立案侦查的情形,最近 36 个月内不存在因与任何上市 公司重大资产重组相关的内幕交易被中国证券监督管理委员会作出行政处罚或 者被司法机关 ...
衢州发展: 第十二届监事会第五次会议决议公告
Zheng Quan Zhi Xing· 2025-08-12 16:23
证券代码:600208 证券简称:衢州发展 公告编号:2025-045 衢州信安发展股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 衢州信安发展股份有限公司(以下简称"公司")第十二届监事 会第五次会议于2025年8月8日以邮件、短信等方式发出通知,会议于 会议应到监事3名,实到3名。会议的召开符合《中华人民共和国公司 法》(以下简称《公司法》)和《公司章程》规定。会议由监事会主 席陈夏林主持。会议审议并通过了以下议案: 一、以3票同意,0票反对,0票弃权审议通过了《关于公司发行 股份购买资产并募集配套资金暨关联交易符合相关法律法规的议案》 公司拟通过发行股份方式购买广东先导稀材股份有限公司(以下 简称"先导稀材")等先导电子科技股份有限公司(以下简称"先导 电科"或"标的公司")48名股东(以下简称"交易对方")合计持 有的先导电科95.4559%股份(以下简称"标的资产"),同时拟向不 超过35名特定投资者发行股票募集配套资金(以下简称"本次交易" 或"本次重组")。 本议案尚需提交公司股东大会审议。 三、以 ...
衢州发展: 董事会关于本次交易符合《上市公司监管指引第9号——上市公司筹划和实施重大资产重组的监管要求》第四条规定的说明
Zheng Quan Zhi Xing· 2025-08-12 16:23
衢州信安发展股份有限公司董事会 关于本次交易符合《上市公司监管指引第 9 号—— 上市公司筹划和实施重大资产重组的监管要求》 第四条规定的说明 衢州信安发展股份有限公司(以下简称"公司")拟通过发行股 份方式购买先导电子科技股份有限公司(以下简称"标的公司") 称"本次交易" 规划、建设施工等有关报批事项,不需要取得相关主管部门的批复 文件,公司已在《衢州信安发展股份有限公司发行股份购买资产并 募集配套资金暨关联交易预案》中详细披露了本次交易已经履行及 尚需履行的审批程序,并对可能无法获得批准的风险作出了特别提 示; 整权利,标的资产不存在被限制或禁止转让的情形,标的公司不存 在出资不实或者影响其合法存续的情况,本次交易的标的资产过户 至公司不存在法律障碍; 将合法拥有标的资产,能实际控制标的公司生产经营,有利于公司 在人员、采购、生产、销售、知识产权等方面继续保持独立; 发生重大不利变化,有利于公司增强抗风险能力;有利于公司增强 独立性,不会导致新增重大不利影响的同业竞争,以及严重影响独 立性或者显失公平的关联交易。 综上,公司董事会认为本次交易符合《上市公司监管指引第 9 号——上市公司筹划和实施重大资产 ...